IL-6 is known to drive STAT3 phosphorylation via receptor-associated Janus Kinases, and activation of the IL-6/STAT3 signaling pathway is reported in several inflammation-associated human malignancies, including BC [50]. This evidence concerns the gene IL6 and breast cancer.